FDA Approves COVID-19 Booster Shots for Children Ages 12-15 Years
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: Expand the use of a single booster dose to include use in individuals 12 through 15 years of age. Shorten the... Continue reading→
Cathedral City’s Weekly Newsletter
Click on the following link to read this week’s newsletter: http://bit.ly/issue-324 Related posts: No related posts.
“Dinner with Patsi” Raises Money for the Boys & Girls Club of Cathedral City
The December “Dinner with Patsi” held at El Portal Mexican Restaurant in Cathedral City raised $1,026.00 for the Boys & Girls Club of Cathedral. Executive Director Scott Robinson accepted the funds raised by the community who simply throw their loose... Continue reading→
Cathedral City Hiring for a Facilities and Field Superintendent
The City of Cathedral is now hiring for a Facilities and Field Superintendent. The ideal candidate will have five (5) years of increasingly responsible maintenance, facilities or construction experience, including at least three (3) years of supervision or management and... Continue reading→
Cathedral City’s Weekly Newsletter
Click on the following link to read this week’s newsletter: http://bit.ly/issue-323 Related posts: No related posts.
Tower Market – Cathedral City Now Open
The new Tower Market located at the northwest corner of Date Palm Drive and Ortega Road – across the street from U.S. Post Office has officially opened. The 5,238 square foot market offers a hybrid of products typical in a... Continue reading→
FDA Gives Authorization for Pill Treatment of COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of... Continue reading→
Cathedral City’s Weekly Newsletter
Click on the following link to read this week’s newsletter: http://bit.ly/issue-322 Related posts: No related posts.